Bill115th CongressFiled Apr 20, 2017Health
H.R. 2113
Speeding Access to Already Approved Pharmaceuticals Act of 2017
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Apr 20, 2017)
Speeding Access to Already Approved Pharmaceuticals Act of 2017
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to facilitate the development and expedite the review of a new drug, biological product, or medical device that has been approved in the European Union.
What just happenedApr 21, 2017
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Stivers, Steve [R-OH-15](R-OH)Sponsor
2 cosponsors1 D1 R
2cosponsors1committees4actions7subjects
- Introduced in HouseApr 20, 2017
- Apr 21, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 20, 2017IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Apr 20, 2017IntroReferralIntro-H
Introduced in House
- Apr 20, 2017IntroReferral1000
Introduced in House